Actionable news
All posts from Actionable news
Actionable news in ACAD: ACADIA Pharmaceuticals Inc.,

​Update on ACADIA Pharmaceuticals

Since reporting a delay for its Phase II Alzheimer’s disease agitation study, ACADIA Pharmaceuticals (ACAD) is off around 22 percent since June.

On August 4 the company reported second quarter losses of $0.63 per share. Revenue (of $1 million) is not meaningful at this...